VERTEX PHARMACEUTICALS INC / MA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
VERTEX PHARMACEUTICALS INC / MA has filed 3,632 SEC EDGAR filings since 15 Feb 1995

SEC filing history

Showing 126-150 of 1,000 matching filings.

Per page
25
Current page
6
144 File 000-19319

144 filing

Filing date
18 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
18 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
18 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Feb 2026
Reporting date
10 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-42126

SCHEDULE 13G/A filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-19319

144 filing

Filing date
11 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .